rucaparib: clinical activity in relapsed ovarian cancer
Published 3 years ago • 84 plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
1:41
the clinical activity of rucaparib in patients with ovarian cancer
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial
-
2:58
rucaparib for relapsed ovarian cancer: safety profile
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
2:07
rucaparib in platinum-sensitive ovarian cancer
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
4:20
rucaparib explored for high-risk ovarian cancer
-
5:18
rucaparib for ovarian cancer
-
5:33
recurrent advanced ovarian cancer: case impressions
-
6:49
platinum-sensitive relapsed ovarian cancer: rucaparib
-
1:42
phase iii results for rucaparib in ovarian cancer
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
9:31
ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer
-
5:26
case 3: parp inhibition in recurrent ovarian cancer
-
2:09
rucaparib maintenance for recurrent ovarian carcinoma
-
2:18
parp inhibition in recurrent ovarian cancer